Drugs / Travoprost 0.004%+Timolol 0.5% ophthalmic solution
Travoprost 0.004%+Timolol 0.5% ophthalmic solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01327599 | Aug 2011 → Nov 2012 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Travoprost 0.004%+Timolol 0.5% ophthalmic solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01327599 ↗ |
| Route | Topical | “Fixed dose combination topical ocular agent” NCT01327599 ↗ |